COPD - A neglected disease

Lancet

Volumn 364, Issue 9434, 2004, Pages 564-565

  Barnes, Peter J ^a   Kleinert, Sabine ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b THE LANCET   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AIRWAY OBSTRUCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DISEASE COURSE; GENETIC RISK; HEALTH CARE COST; HUMAN; MORTALITY; NOTE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; SMOKING CESSATION; TREATMENT PLANNING; WORLD HEALTH ORGANIZATION;

EID: 4143080717     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)16866-9     Document Type: Note

References (6)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Workshop Report, 2003: www.goldcopd.com/workshop/ index.html (accessed July 27, 2004).
2. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med. 4:1998;1241-1243
3. Murray CJL, Lopez AD, Mathers CD, Stein C. The Global Burden of Disease 2000 Project: global programme on evidence for health policy discussion, paper #36. Geneva: WHO, 2001.
4. European Respiratory Society. European Lung White Book. Lausanne, Switzerland: European Respiratory Society, 2003; 1-182.
5. Ait-Khaled N, Enarson D, Bousquet J. Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management. Bull World Health Organ. 79:2001;971-979
6. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J. 22:2003;672-688